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Oxidative DNA damage results from DNA adducts such as 8-oxo-7, 8 dihydro-20-deoxyguanosine (8-oxo-dG), which is a
pro-mutagenic lesion. No known association between 8-oxo-dG, disease progression and survival exists in colorectal cancer (CRC).
We examined levels of 8-oxo-dG in sporadic CRC to determine its relationship with pathological stage and outcome. A total of 143
CRC patients and 105 non-cancer patients were studied. Nuclear and cytoplasmic 8-oxo-dG was assessed using immuno-
histochemistry. Double immunofluorescence using 8-oxo-dG and manganese superoxide dismutase (MnSOD) antibodies localised
cytoplasmic 8-oxo-dG. Apoptosis was detected using TUNEL. Nuclear staining levels were similar in tumour tissue and matched
normal mucosa in both epithelial (P¼0.22) and stromal (P¼0.85) cells. Epithelial cytoplasmic staining was greater in tumour tissue
(Po0.001). Double immunofluorescence localised cytoplasmic 8-oxo-dG to mitochondria. Epithelial and stromal nuclear 8-oxo-dG
decreased with local disease spread, but highest levels were found in distant disease (Po0.01). Survival was related to epithelial
nuclear and stromal staining in normal mucosa (Po0.001) and tumour (Po0.01) but was unrelated to cytoplasmic staining. Normal
control cells in tissue from cancer patients with high levels of 8-oxo-dG failed to undergo cell death. 8-oxo-dG may be an important
biomarker of disease risk, progression and survival for CRC patients.
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Colorectal cancer is one of the commonest cancers in the Western
World (Ferlay et al, 2007) and genetic events associated with
tumour initiation and progression have been extensively studied
(Fearon and Vogelstein, 1990). The majority of mutations found in
sporadic colorectal cancer are due to single-base substitutions
(Sjoblom et al, 2006) such as GC to TA transversions.
Oxidative stress is defined as a disturbance in the balance
between the production of reactive oxygen species and antioxidant
defences. It is associated with aging and implicated in a variety of
disease processes including atherosclerosis, diabetes mellitus and
cancer (Pacifici and Davies, 1991; Maritim et al, 2003; Valko et al,
2004; Minuz et al, 2006). Endogenous sources of reactive oxygen
species production include oxidative phosphorylation and inflam-
matory cell activation, and despite multiple conserved redox
modulating systems, a proportion of reactive oxygen species
continuously escape the mitochondrial respiratory chain. The
significance of reactive oxygen species within antioxidant systems
and its role in carcinogenesis is not fully understood. Enhanced
antioxidant mechanisms in gastrointestinal tumour cells in vivo
are associated with chemo-resistance, metastasis and poor
prognosis, whereas many in vitro studies suggest that antioxidant
enzymes have tumour-suppressing properties (Janssen et al, 1998;
Toh et al, 2000), although the majority of conflicting results may
be explained by reference to the net redox status of malignant cells
(Kinnula and Crapo, 2004).
The DNA adduct, 8-oxo-7, 8-dihydro-20-deoxyguanine (8-oxo-
dG) is formed by the reaction of OH radical with the DNA guanine
base. It is a pro-mutagenic lesion that mispairs with adenine
leading to GC to TA transversions. This oxidative DNA damage is
repaired primarily by the base excision repair pathway incorpor-
ating the glycosylases OGG1, MYH and NUDT1 (Chow et al, 2004).
Few data are available on 8-oxo-dG levels in colorectal diseases
(Dincer et al, 2007) and the levels of 8-oxo-dG in relation to
disease progression and survival has not been studied in colorectal
tumours. We assessed nuclear and mitochondrial 8-oxo-dG
staining in tumour and matched normal tissues and in tissues
from a non-cancer control population.
MATERIALS AND METHODS
Patients and tissue collection
This study included 143 randomly selected patients with colorectal
cancer (median age 67 years; range 29–87 years; 73 men, 70
women) treated surgically in the Centre for Colorectal Disease,
St Vincent’s University Hospital, Dublin, Ireland between November
1991 and August 2002. We also studied 105 consecutive patients
(median age 45 years; range, 17–87 years; 41 men, 64 women)
undergoing colonoscopy for investigation of altered bowel
habit and whose investigations were normal. These investi-
gations included histological examination of colonic biopsies,
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Figure 1 (A) 8-oxo-dG nuclear staining (weak cytoplasmic staining ) in normal non-adjacent mucosa vs (B) strong 8-oxo-dG cytoplasmic staining in the
matching tumour tissue. (C–F) Represent negative, weak, moderate and strong intensity levels in tumour epithelial cells. (G) Graphical representation of
8-oxo-dG percent positivity in normal non-adjacent mucosa vs matched tumour tissue in cancer patients using Wilcoxon’s signed rank test.
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(erythrocyte sedimentation rate and C reactive protein).
Following surgery, tumours were fixed in 1% formalin and
embedded in paraffin. Tumours were staged using the WHO
classification (Morson, 1976). There were 13 Stage I, 46 Stage II, 39
Stage III and 45 Stage IV cancers. Colorectal mucosal tissue remote
from the tumour and adjacent to histologically normal mucosa was
obtained for 99 of the 143 cases. Patients were followed up at 6
monthly intervals and median follow up of patients alive at the end
of study was 6.7 years. Ethical approval was granted by the
St Vincent’s Hospital Ethics and Medical Research Committee to
conduct this study.
Tissue microarray construction
For all cancer cases, haematoxylin- and eosin-stained slides from
formalin-fixed, paraffin-embedded colorectal tumour blocks were
used to identify specific areas of the cancer. These areas were
aligned with the tissue block and four 6mm cores taken and
transferred to a recipient block using a Tissue Microarrayer
(Beecher Instruments, Silver Spring, MD, USA). Here, 4mm
sections were cut for immunohistochemical studies and
mounted onto SuperFrost Plus adhesive slides (Menzel-Glaser,
Braunschweig, Germany).
8-oxo-dG immunohistochemistry
Immunohistochemistry was performed using colorectal tissue
microarray slides and the DAKO ChemMate Envision Kit (Dako,
Glostrup, Denmark). Then, 4mm sections were baked for 30min at
901C, deparaffinised in xylene and re-hydrated in alcohol and
deionised water. All slides in this study were processed and stained
on the same day.
Antigen retrieval was performed using 1500ml antigen retrieval
solution (15ml of 1 M sodium citrate and 15ml of 1 M citric acid in
deionised water, pH 6.0). This solution was heated in a pressure
cooker (Menarini Diagnostics, Berkshire, England) with the lid off
for 20min at full power in an 800W microwave. Slides were placed
in the pressure cooker, lid sealed and heated at full power until the
pressure valve popped up (5–7min). Slides remained incubated at
full power for a further 4min. The pressure cooker was removed
from the microwave and the lid removed once the pressure
equalised (takes approximately 10min). Slides were washed in PBS
and 0.05% Tween for 10min. Non-specific binding was blocked
using 10% casein in PBS for 10min at room temperature. 8-oxo-dG
mouse monoclonal antibody (Genox, Baltimore, MD, USA) was
diluted 1:40 in antibody diluent (Dako) and incubated on slides
for 2h at room temperature in a humidified chamber. An IgG
control antibody and the elimination of the primary antibody were
used as negative controls.
Endogenous peroxidase activity was blocked using 3% hydrogen
peroxide for 7min at room temperature. Slides were washed as
stated above followed by incubation with secondary antibody/HRP
(Dako) for 30min at room temperature.
Slides were washed and incubated with 1:50 DAB in substrate
buffer for 10min at room temperature, followed by a PBS wash and
placed in running water for 5min. DAB staining was intensified by
application of 0.5% copper sulphate to each slide for 10min. Slides
were washed and counterstained with 1:4 Mayer’s haematoxylin
(BDH Laboratories, Poole, UK) for 20s followed by a water wash
for 5min.
Tissues were dehydrated and mounted using Pertex mounting
media and images were captured using Olympus DP50 light
microscope and AnalySIS software (Soft Imaging System Corpora-
tion, Lakewood, CO, USA).
Immunohistochemical scoring
Four cores were examined for each case and both epithelial
and stromal cells were assessed for percentage of nuclear and
cytoplasmic cells staining positivity and associated nuclear
and cytoplasmic staining intensity. Intensity was graded as
Figure 2 Immunofluorescence co-localisation of 8-oxo-dG and MnSOD. DAPI DNA stain (blue), 8-oxo-dG (red) and MnSOD (green). Upper panels,
a tumour case with no cytoplasmic 8-oxo-dG (shows nuclear 8-oxo-dG) with abundant cytoplasmic MnSOD staining. Lower panels, represent a tumour
case with abundant cytoplasmic 8-oxo-dG and MnSOD demonstrating co-localisation (yellow). Magnification  40.
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value of each parameter was calculated from the results of the four
cores. The scoring was by consensus review (JS and JOS). The
reviewers were blinded to the original diagnosis and the patient
outcomes at the time of review.
Immunofluorescence
Immunofluorescence was performed using monoclonal 8-oxo-dG
and polyclonal manganese superoxide dismutase (MnSOD)
antibodies. Antigen retrieval was performed as described above.
Non-specific binding was blocked using 10% casein in PBS
for 10min at room temperature. An antibody mix of 8-oxo-dG
mouse monoclonal antibody (Genox) (1:40 dilution) and rabbit
anti MnSOD polyclonal antibody (Nventa Biopharmaceuticals,
San Diego, CA, USA) (1:200 dilution) was incubated on slides for
2h at room temperature in a humidified chamber. Negative
controls incorporated neither of the primary antibodies. Biotiny-
lated horse anti-mouse antibody (1:200 dilution) (Vector Labora-
tories, Peterborough, UK) and incubated on slides for 30min.
Mouse and biotin CY3 (SigmaAldrich, Gillingham, UK) (1:100
dilution) and goat and rabbit FITC (SigmaAldrich) (1:50 dilution)
fluorescent secondary antibodies were applied to slides for 30min.
Slides were counterstained with a 10ngml DAPI (SigmaAldrich)
for 5min. Slides were incubated with prolonged anti-fade solution
and immunofluorescence images were captured using a Zeiss
fluorescence microscope.
TUNEL and 8-oxo-dG immunofluorescence
Apoptotic cells within the tissue were detected by terminal
deoxynucleotidyl transferase-mediated dUTP nick-end labelling
(TUNEL). Slides were treated with the Fluorometric Apoptosis
(Promega, Madison, WI, USA) according to the instructions of the
manufacturer for paraffin-embedded tissues. Here, 8-oxo-dG
immunofluorescence was performed as described above.
Statistical analysis
Continuous data are presented as medians and interquartile
ranges. Non-parametric data were assessed using Wilcoxon’s rank
sum test, Wilcoxon’s signed rank test, the Kruskal–Wallace test or
Spearman’s rank correlation coefficient as appropriate.
Differences between proportions were assessed using the w
2 test.
The distribution of 8-oxo-dG staining was divided into tertiles to
develop usable groups to determine the effect of staining on
survival. The resulting groups contained different numbers of
patients, but were as close to tertiles as it was possible to achieve.
Kaplan–Meier survival curves were constructed with cancer-
related mortality as the end point. Differences in survival between
groups were assessed using the log-rank test. Multivariate survival
analyses were performed with the Cox proportional hazards model
using the Statistical Package for the Social Sciences (SPSS, Chicago,
IL, USA). All P-values are two-sided and P-values less than 0.05
were considered statistically significant in all analyses.
RESULTS
8-oxo-dG staining in tumour vs matching normal non-
adjacent mucosa in cancer patients
Figure 1A and B shows representative images of 8-oxo-dG staining
in normal adjacent mucosa from a cancer patient and matching
tumour tissue respectively. High levels of nuclear staining is
evident in normal non-adjacent epithelial cells (Figure 1A),
whereas high levels of cytoplasmic staining is evident in tumour
epithelial cells (Figure 1B). Panels c–f show representative images
of the different nuclear 8-oxo-dG intensities ranging from negative
to weak, moderate and strong.
Figure 1G illustrates graphically the percentage of positive cells
and cellular localisation of 8-oxo-dG in tumour when compared
with non-adjacent normal tissue. Percentage nuclear staining was
similar in matched normal non-adjacent mucosa and tumour
tissue in both epithelial (P¼0.22) and stromal (P¼0.85) cells.
However, percentage epithelial cytoplasmic staining was greater in
tumour tissue (Po0.001) 8- oxo-dG staining in both tumour
tissues and non-adjacent mucosa was unrelated to age (data not
shown).
Immunofluorescence co-localisation of MnSOD
and 8-oxo-dG in tumour
Double immunofluorescence staining of 8-oxo-dG and MnSOD
showed that cytoplasmic 8-oxo-dG is mitochondrial in nature.
Figure 2 (upper panel) illustrates a colorectal cancer case where
no 8-oxo-dG cytoplasmic staining is detected (no red staining)
but abundant cytoplasmic MnSOD staining is evident (green).
In contrast, Figure 2 (lower panel) shows co-localisation of
cytoplasmic 8-oxo-dG and MnSOD staining (yellow).
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Figure 3 Graphical representation of 8-oxo-dG nuclear percent
positivity in epithelium (A) and stromal cells (B) for each colorectal
cancer disease stage.
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Figure 3A and B shows the relationship between epithelial and
stromal nuclear 8-oxo-dG staining and anatomical progression.
Levels were relatively high in early stage disease and tended to
decrease with advancing local spread. However, highest levels were
found in the primary tumours of patients with distant metastases
(stage IV) and similar patterns were seen in the epithelial and
stromal nuclei of both tumour and non-adjacent normal mucosal
cells. Cytoplasmic staining was unrelated to stage (data not
shown). Long-term survival was closely associated with tumour
stage (Po0.0001) (data not shown). In addition, poor outcome was
related to high levels of 8-oxo-dG epithelial nuclear staining in
normal non-adjacent mucosa (uncorrected log-rank test,
P¼0.0003 (corrected for age, gender and tumour stage in the
proportional hazards model, relative risk 2.2; 95% confidence
intervals 1.3–3.6, P¼0.002)) and tumour tissue (uncorrected,
P¼0.002 (corrected, RR 1.7; 95% CI 0.8–3.4; P¼0.15)). Poor
outcome was also associated with high levels of stromal nuclear
staining in normal non-adjacent mucosa (uncorrected, Po0.0001
(corrected, RR 2.2; 95% CI 1.3–3.8; P¼0.005)) and tumour tissue
(uncorrected, P¼0.002 (corrected, RR 2.7; 95% CI 1.3–5.5;
P¼0.006)). Survival was unrelated to cytoplasmic staining in
either tumour or normal mucosa (Figure 4). Staining intensity
levels did not correlate with survival (data shown).
Secondary analyses were performed to include only those
patients undergoing curative surgery. Again, survival, corrected
for age, gender and tumour stage was related to 8-oxo-dG
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Figure 4 Survival of colorectal cancer patients stratified by epithelial and stromal 8-oxo-dG staining.
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sepithelial nuclear staining in normal non-adjacent mucosa (RR 3.4;
95% CI 1.6–7.4; P¼0.002) and tumour tissue (RR 4.1; 95%
CI 1.3–12.5; P¼0.01), and with stromal nuclear staining in normal
non-adjacent mucosa (RR 3.5; 95% CI 1.5–8.1; P¼0.003) but not
with stromal nuclear staining in tumour tissue (RR 2.5; 95% CI
0.7–8.7; P¼0.14).
8-oxo-dG staining in normal controls
Epithelial nuclear and cytoplasmic and stromal nuclear 8-oxo-dG
staining was also examined in the colonic mucosa of 105 patients
without structural bowel diseases to determine the effect of age and
gender on 8-oxo-dG staining. No significant associations were
found (data not shown).
8-oxo-dG levels and apoptosis in cancer patients and
normal controls
Representative confocal microscopy images of dual labelling
TUNEL (green fluorescence) and 8-oxo-dG (red fluorescence) are
shown in Figure 5. Normal colonic cells in tissue from patients
without colorectal cancer who have high levels of 8-oxo-dG are
seen to undergo apoptosis (upper panels). However, normal
colonic cells in tissue from cancer patients with high 8-oxo-dG
levels fail to undergo apoptosis (lower panels).
DISCUSSION
Several methods have been developed to measure 8-oxo-dG levels
in biologic samples. These include high performance liquid
chromatography coupled with electrochemical detection, gas
chromatography and
32P postlabelling (Halliwell, 1999). How-
ever, results from these labour-intensive methods have been
difficult to reproduce and there is disagreement both with regard
to actual values and variability within cells and tissue specimens.
Indeed, a European Standards Committee on Oxidative DNA Damage
(ESCODD) has been established because of such discrepancies
with identification of drawbacks associated with these methods
(Gedik and Collins, 2005). In this study, we used immunohistochem-
ical methods as it allowed us to localise 8-oxo-dG to different cell
types without the risk of artifactual production of 8-oxo-dG
associated with DNA extraction and hydrolytic processes. This
antibody is specific to oxidised DNA and does not recognise RNA
(Toyokuni et al, 1997).
We found substantial staining of 8-oxo-dG in both the epithelial
and stromal nuclei of tissues from the normal colon of both
control and cancer patients in addition to cancer tissues taken
from the latter. High levels of 8-oxo-dG have previously been
detected in the blood of patients with various cancers including
oesophagus, lung and colon (Gackowski et al, 2002, 2005; Breton
et al, 2005) whereas oxidative stress is also linked to chronic
inflammatory states including inflammatory bowel diseases,
known to be associated with colorectal cancer risk (Pohl et al,
2000; Dincer et al, 2007). Other risk factors for colorectal cancer
include obesity and insulin resistance, themselves closely asso-
ciated with oxidative stress (Urakawa et al, 2003) and it is clear
that these various interrelationships are complex. Mechanisms
whereby oxidative damage could result in cancer development
have been proposed and a system that includes oxidative damage
and stress resulting in the formation of pro-mutagenic 8-oxo-dG
with subsequent widespread G:C to T:A transversions supports the
mutator phenotype hypothesis (Loeb et al, 1974). Such a
hypothesis seems plausible, although still remaining speculative
(Olinski et al, 2003).
We studied 8-oxo-dG staining in the colonic tissues of a large
number of patients without structural bowel disease and found no
association between oxidative damage and age. In relation to our
cancer cohort, we found that tumour tissues had higher levels of
cytoplasmic 8-oxo-dG than non-adjacent colonic mucosa.
However, the main finding from our study was that high levels
of 8-oxo-dG were associated with poor survival, both in
uncorrected analyses and when corrected for tumour stage. This
remained true even when patients with metastatic disease were
excluded in secondary analyses. It is also clear from a review
of Figure 4 that it was only those patients with the highest levels of
Figure 5 Representative confocal microscopy images of dual labelling TUNEL (green fluorescence) and 8-oxo-dG (red fluorescence). Upper panels –
normal colonic cells from patients without colorectal cancer that have high levels of 8-oxo-dG are seen to undergo apoptosis. Lower panels – normal
colonic cells from cancer patients with high levels of 8-oxo-dG fail to undergo apoptosis.
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those with medium staining levels behaved similarly to those with
low staining levels.
Our cutoff points were constructed arbitrarily by dividing our
cohort into tertiles, but it is probable that much more powerful
associations with outcome would be found using additional
discriminatory analyses such as the maximal log-rank test (Peto
et al, 1977). Our findings relating to colorectal cancer have not
been described earlier, but high levels of 8-oxo-dG have been
associated with poor outcome in non small cell lung cancer and
renal cell carcinoma (Miyake et al,2 0 0 4 ;S h e net al,2 0 0 7 )w h e r e a s
oxidative damage in non-cancerous liver tissues also appears to
predict recurrence of hepatocellular cancer (Matsumoto et al, 2003).
As survival was associated with 8-oxo-dG staining and also
closely associated with anatomical spread, one might have
expected a positive association between 8-oxo-dG staining and
advancing tumour stage. However, this was not the case, especially
in those undergoing curative surgery. If anything, 8-oxo-dG
nuclear staining was relatively high in early disease and declined
somewhat with advancing tumour stage until the development of
distant metastases when there was a sharp rise again. Thus, the
effect of intranuclear oxidative damage on clinical progression was
clearly independent of pathological stage, especially in those
without distant metastases, as confirmed by our multivariate
analyses. In contrast, although we found considerable cytoplasmic
staining in epithelial cells, and further identified it as mitochon-
drial in nature, it is clear that this widespread mitochondrial
damage was unimportant with regard to both anatomical and
clinical disease progression.
What is the pathophysiological explanation for our findings in
patients with and without colorectal cancer? Previous studies
suggest that 8-oxo-dG accumulation may be due to decreased DNA
repair capacity (Gackowski et al, 2003). We found that colonic cells
with high levels of nuclear 8-oxo-dG taken from non-colorectal
cancer patients readily undergo apoptosis. However, in cancer
patients, normal colonic cells with high levels of 8- oxo-dG did not
undergo cell death and it is possible that the mutator phenotype
(Loeb et al, 2003) may predispose these cells to further
accumulation of mutations and genomic instability. As to our
findings in the different colorectal cancer stages, it is possible that
the high levels of nuclear oxidative damage found in early stage
disease may contribute to this mutator phenotype with a
subsequent decline as tumours progress locally. In those with
distant metastases, the sharp rise in nuclear 8-oxo-dG levels may
correlate with a more hypoxic tissue environment in late stage
metastatic disease with upregulation of HIF-1 and VEGF levels
(Jiang et al, 2003) and it is clear that rises also relate to clinical
progression independent of tumour stage. Ultimately, the role of
8-oxo-dG and reactive oxygen species in colorectal cancer remains
speculative, but numerous epidemiological, in vitro and in vivo
animal studies suggest that oxidative damage may be important in
cancer initiation and progression and that antioxidants may be
cytoprotective. It will be interesting to further assess the precise
contribution made by 8-oxo-dG and similar compounds to these
systems.
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